Search results
16 paź 2021 · It appears that this is the first report of a plasma HIV RNA increase after vaccination with an mRNA COVID-19 vaccine in a patient with documented adherence, possibly reflecting induced proviral transcription.
9 kwi 2022 · Such concern has prompted hesitancy to deploy available, safe, and efficacious adenovirus-based COVID-19 vaccines in countries with high HIV-1 incidence.
22 wrz 2021 · After an initial Emergency Use Authorization (EUA) that was issued in December 2020 and then followed by a second one in February 2021 by the U.S. Food and Drug Administration (FDA), the two mRNA vaccines produced by Pfizer (Pearl River, NY, USA) and Moderna (Cambridge, MA, USA) are pending final approval for routine use as of August 2021.
18 cze 2021 · At this point in the COVID-19 pandemic, with vaccine roll-out ongoing, the most urgent question facing people with HIV and their health-care providers is whether HIV modulates the immune response to and subsequent effectiveness of the SARS-CoV-2 vaccines in preventing severe COVID-19 disease.
19 sie 2022 · Vaccination with a SARS-CoV-2 mRNA vaccine revealed HIV hiding in immune cells in blood from people with HIV, according to lab research led by Weill Cornell Medicine investigators.
26 paź 2021 · COVID-19 vaccine side effects include fatigue, redness, fever, arthralgia, and headache, and may resemble symptoms of HIV seroconversion illness, thus impeding the diagnosis of HIV [3].
4 sie 2021 · The Pfizer and Moderna vaccines against SARS-CoV-2 produce strong antibody responses in people with HIV and similar antibody and cellular immune responses in people with and without HIV, two studies published in the journals AIDS and Clinical Infectious Diseases show.
